Ilika Drives Forward in Solid-State Battery Revolution

Ilika Plc

Automakers and industrial players are actively investing in solid-state development, recognising its potential to redefine electric mobility and power systems. New cells under development are demonstrating impressive charge speeds and energy performance, with some capable of reaching high charge levels in under 20 minutes. Several companies aim to bring solid-state products into demonstration or early production stages within the next few years.

Within this dynamic sector, one company developing a clear niche is Ilika plc. The firm’s focus on solid-state technology spans both micro-scale and large-format cells. Its Stereax microbatteries target high-value applications like medical implants and industrial sensors, where reliability, longevity, and miniaturisation are key. At the same time, Ilika’s Goliath programme is building momentum in the automotive and high-power segment, with prototype cells already achieving industry benchmarks. Ilika’s use of an oxide-ceramic electrolyte, compatible with existing manufacturing lines, reduces the need for completely new infrastructure, a major advantage when scaling to volume production.

As interest in advanced battery technologies intensifies, firms that combine proven science with manufacturability are gaining traction. Ilika’s strategy to balance technical innovation with practical deployment makes it a strong participant in the ongoing shift to solid-state power.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.

Search